成人无码高潮av在线观看_欧洲极品少妇_夂久亚州精华国产精华华液_在线观看亚洲AV每日更新无码_亚洲国产精品无码久久一线_亚洲精品区午夜亚洲精品区

創(chuàng)生控股Trauson Holdings

　 創(chuàng)生控股有限公司（「創(chuàng)生控股」或「本公司」）及其附屬公司（統(tǒng)稱「本集團」或「集團」）是中國領(lǐng)先的骨科產(chǎn)品生產(chǎn)商，主要從事設(shè)計、制造及銷售多種創(chuàng)傷及脊柱骨科植入物，以及相關(guān)手術(shù)工具。集團正式始建于二零零二年十二月，由現(xiàn)任董事會主席兼首席執(zhí)行官錢福卿先生創(chuàng)辦，是中國骨科市場的首批進入者之一。根據(jù)權(quán)威機構(gòu)統(tǒng)計，創(chuàng)生控股以市場份額計算是中國骨科產(chǎn)品生產(chǎn)商中最大的創(chuàng)傷產(chǎn)品生產(chǎn)商及三大脊柱產(chǎn)品生產(chǎn)商之一。

　　截至二零一零年十二月三十一日，集團共有一百余種產(chǎn)品，并透過旗下品牌－「創(chuàng)生」及「奧斯邁」銷售。集團龐大的分銷網(wǎng)絡(luò)覆蓋全國三十個省市及自治區(qū)，有超過三千家醫(yī)院認(rèn)可創(chuàng)生控股為骨科產(chǎn)品供貨商。

　　集團秉承「專業(yè)、專注、專心」的理念，自創(chuàng)建以來取得了迅速的增長。創(chuàng)生控股于二零一零年六月二十九日在其發(fā)展過程中取得了一個重要的里程碑，成功于香港聯(lián)合交易所有限公司（「香港聯(lián)交所」）主板上市（股份代號 325.HK ），成為為數(shù)不多的進入國際資本市場的中國骨科器械企業(yè)之一。
 

　　 創(chuàng)生控股旗下?lián)碛袃杉抑饕娜Y控股企業(yè)：創(chuàng)生醫(yī)療器械（江蘇）有限公司（「創(chuàng)生江蘇」已于二零一一年三月二十三日更名為創(chuàng)生醫(yī)療器械（中國）有限公司）和常州奧斯邁醫(yī)療器械有限公司（「常州奧斯邁」）。于二零一零年十二月三十一日，本集團分別有三個廠區(qū)，總樓面面積達107,100平方米，集團的總資產(chǎn)達人民幣10.23億元。

　　集團擁有精良的制造加工設(shè)備及測量儀器，通過了中國醫(yī)療器械質(zhì)量認(rèn)證中心的ISO13485-2003質(zhì)量體系認(rèn)證，截止2010年底，公司獲得產(chǎn)品注冊證書100份，主要產(chǎn)品于2007年獲CE認(rèn)證證書、2008年獲美國藥監(jiān)局510（K）許可。「創(chuàng)生」商標(biāo)被認(rèn)定為中國馳名商標(biāo)，是中國骨科領(lǐng)域唯一獲此殊榮的公司。

Trauson Holdings Company Limited (Trauson Holdings or the Company) and its subsidiaries (together as the Group) is a leading manufacturer of orthopaedic products in China. The Group was founded in December 2002 by the chairman and chief executive officer,Mr.Qian Fuqing,who is one of the forerunners in Chian''''''''''''''''s orthopaedic industry. According to an authoritative statistics, Trauson Holdings was the largest domestic producer of trauma products and one of the top three domestic producers of spine products in China by market share.
 

As at 31 December 2010, the Group had over 100 products marketed under its own brands, Trauson and Orthmed. The Groups extensive distribution network covered over 30 provinces and autonomous regions across China, with over 3,000 hospitals recognizing Trauson Holdings as their supplier of orthopaedic products.

Embracing the philosophy of professionalism, focus and concentration, the Group has experienced rapid growth since its inception. On 29 June 2010, Trauson Holdings reached an important milestone in its development when it was successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited (the HKSE) (stock code: 325.HK), becoming one of the first China orthopaedic device companies to access the international capital market.

The Group has two principal and wholly-owned operating subsidiaries, Trauson (Jiangsu) Medical Instrument Company Limited (Trauson Jiangsu, which has been renamed as Trauson Medical Instrument (China) Company Limited with effect from 23 March 2011) and Changzhou Orthmed Medical Instrument Company Limited (Changzhou Orthmed). As at 31 December 2010, the Group had three production facilities with an aggregate floor area of 107,100 square metres, and total assets of approximately RMB1,023 million.

With the introduction of sophisticated manufacturing and processing equipments and measuring instruments, Trauson Holdings has also obtained the ISO13485-2003 certification of the China Quality Certification Center for Medical Devices. By the end of 2010, Trauson Holdings had received 100 registration certificates for its products. In addition, Trauson Holdings main product had attained CE marks and US FDA 510(K), in 2007 and 2008 respectively. TRAUSON is the only trademark that has been awarded the Well-known Chinese Brand in Chinas orthopaedic industry.